Author/ Authors/ Presenter/ Presenters/ Panelists:

John AkinboteFollow

Location

D34005

Start Date

3-31-2023 1:30 PM

End Date

3-31-2023 2:45 PM

Presenter

John Akinbote

Abstract

Authors:

John Akinbote

Kibble Courtney

Jesus Reyes

William Matallana

Veronica Cardenas



The concept of trauma-informed care (TIC) has been over flogged in the traditional healthcare settings of patients with mental disorders with some success but there is a need to ascertain its impact amongst patients in recovery for drug addiction. It is pertinent to state that patients with early life adverse childhood events (ACEs), ongoing stressors and significant life events remain vital targets of trauma -related diagnostic entities since these factors play role in predicting the predisposing, precipitating and perpetuating factors in the dynamics of opioid use disorder and other addictive problems. A clear understanding of how the intrinsic and extrinsic stressors culminate in trauma or how a single significant violent experience causes trauma needs more evaluation among people with addiction. Although most healthcare providers need to have an in-depth knowledge of how these traumatic experiences can influence the screening, assessment, treatment planning for these populations, there is need to use structured care backed by evidence-based therapies to see how certain symptoms such as anxiety and depression can be used to assess the effectiveness of such interventions. It will be important to assess the outcome of such interventions in behavioral health services using randomized control trials to ascertain its efficacy. Using instruments such as Hospital Anxiety and Depression Scale (HADS) to assess anxiety traits and the Trauma Assessment for Adults (TAA) to assess level of trauma effects, the impact of trauma-informed care can be ascertained in the recovery process of patients on medication assisted treatment (MAT) for opioid use disorder (OUD). METHODOLOGY Procedure Adult patients with diagnosis of OUD will be recruited in an out-patient care setting in Chicago. Participants will be assessed for anxiety and depressive symptoms using the HADS in the first stage of research. Those with significant anxiety and depressive symptoms will be randomized into two groups. A group will receive intensive and structured trauma informed care while the other group will not receive trauma informed care for a period of 8 weeks. Improvement in anxiety and depressive symptoms will be assessed using the HADS including level of trauma using the TAA after the 8 weeks period. A comparison between both groups will be made thereafter. Inclusion and Exclusion Criteria 1. Participants with psychotic disorders will be excluded. 2. Pregnant female participants will be excluded. 3. Participants with significant hearing impairment or visual impairment will be excluded. 4. Only participants that give consent will be allowed.to participate in the study Ethical Considerations Participants will be required to sign an informed consent form and will also be free to opt out of the research at any time. Gift cards will be given to participants that agreed to participate at the beginning and termination of the research. The approval will be sought from the Governor State University’s ethical committee and effort will be ensured to follow HIPAA rule of confidentiality. Conclusion The expected outcomes of this double blind randomized controlled trial will be to see how effective use of trauma informed care can better alleviate anxiety symptoms, depressive symptoms and effects of trauma on participants that received the structured informed care compared to those that did not receive. Those that did not receive the care during the research will be provided the same level of trauma informed care for 8 weeks to fulfil the ethical principle of justice.

Presentation File

wf_yes

Share

COinS
 
Mar 31st, 1:30 PM Mar 31st, 2:45 PM

Efficacy of Trauma Informed Care in Reducing Anxiety and Depressive Symptoms Among Patients on Medication Assisted Therapy for Opioid Use Disorder: A Randomised Control Trial

D34005

Authors:

John Akinbote

Kibble Courtney

Jesus Reyes

William Matallana

Veronica Cardenas



The concept of trauma-informed care (TIC) has been over flogged in the traditional healthcare settings of patients with mental disorders with some success but there is a need to ascertain its impact amongst patients in recovery for drug addiction. It is pertinent to state that patients with early life adverse childhood events (ACEs), ongoing stressors and significant life events remain vital targets of trauma -related diagnostic entities since these factors play role in predicting the predisposing, precipitating and perpetuating factors in the dynamics of opioid use disorder and other addictive problems. A clear understanding of how the intrinsic and extrinsic stressors culminate in trauma or how a single significant violent experience causes trauma needs more evaluation among people with addiction. Although most healthcare providers need to have an in-depth knowledge of how these traumatic experiences can influence the screening, assessment, treatment planning for these populations, there is need to use structured care backed by evidence-based therapies to see how certain symptoms such as anxiety and depression can be used to assess the effectiveness of such interventions. It will be important to assess the outcome of such interventions in behavioral health services using randomized control trials to ascertain its efficacy. Using instruments such as Hospital Anxiety and Depression Scale (HADS) to assess anxiety traits and the Trauma Assessment for Adults (TAA) to assess level of trauma effects, the impact of trauma-informed care can be ascertained in the recovery process of patients on medication assisted treatment (MAT) for opioid use disorder (OUD). METHODOLOGY Procedure Adult patients with diagnosis of OUD will be recruited in an out-patient care setting in Chicago. Participants will be assessed for anxiety and depressive symptoms using the HADS in the first stage of research. Those with significant anxiety and depressive symptoms will be randomized into two groups. A group will receive intensive and structured trauma informed care while the other group will not receive trauma informed care for a period of 8 weeks. Improvement in anxiety and depressive symptoms will be assessed using the HADS including level of trauma using the TAA after the 8 weeks period. A comparison between both groups will be made thereafter. Inclusion and Exclusion Criteria 1. Participants with psychotic disorders will be excluded. 2. Pregnant female participants will be excluded. 3. Participants with significant hearing impairment or visual impairment will be excluded. 4. Only participants that give consent will be allowed.to participate in the study Ethical Considerations Participants will be required to sign an informed consent form and will also be free to opt out of the research at any time. Gift cards will be given to participants that agreed to participate at the beginning and termination of the research. The approval will be sought from the Governor State University’s ethical committee and effort will be ensured to follow HIPAA rule of confidentiality. Conclusion The expected outcomes of this double blind randomized controlled trial will be to see how effective use of trauma informed care can better alleviate anxiety symptoms, depressive symptoms and effects of trauma on participants that received the structured informed care compared to those that did not receive. Those that did not receive the care during the research will be provided the same level of trauma informed care for 8 weeks to fulfil the ethical principle of justice.